US Bancorp
INDV icon

US Bancorp’s Indivior Pharmaceuticals INDV Stock Holding History

US Bancorp’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.13K Buy
125
+93
+291% +$3.37K ﹤0.01% 3644
2026
Q1 		$975 Hold
32
– – ﹤0.01% 3937
2025
Q4 		$1.15K Hold
32
– – ﹤0.01% 3836
2025
Q3 		$772 Hold
32
– – ﹤0.01% 3847
2025
Q2 		$472 Hold
32
– – ﹤0.01% 4011
2025
Q1 		$305 Hold
32
– – ﹤0.01% 4075
2024
Q4 		$398 Hold
32
– – ﹤0.01% 4039
2024
Q3 		$312 Hold
32
– – ﹤0.01% 3984
2024
Q2 		$516 Hold
32
– – ﹤0.01% 3858
2024
Q1 		$685 Hold
32
– – ﹤0.01% 3840
2023
Q4 		$489 Hold
32
– – ﹤0.01% 3847
2023
Q3 		$738 Hold
32
– – ﹤0.01% 3814
2023
Q2 		$762 Buy
+32
New +$734 ﹤0.01% 3836

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

US Bancorp's INDV Position: Q2 2026 in Review

US Bancorp increased its Indivior Pharmaceuticals (INDV) stake by 291% in Q2 2026, buying an estimated $3.37K and bringing the position to 125 shares worth $5.13K. The position accounts for ﹤0.01% of the portfolio, ranked #3644.

US Bancorp first reported a position in INDV in Q2 2023 and has held it in 13 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • US Bancorp held 125 shares of Indivior Pharmaceuticals worth $5.13K as of Q2 2026.
  • US Bancorp bought 93 Indivior Pharmaceuticals shares in Q2 2026, an estimated $3.37K.
  • Indivior Pharmaceuticals made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3644 holding.
  • US Bancorp first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.